Riskpilot← Back to searchSign inGet full accessChromologics ApS
APSActiveCVR 38789953Maskinvej 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 201718 employeeswww.chromologics.com
Revenue 2024
DKK -17,2M
+74% vs 2023
EBITDA margin
170.9%
-40% vs 2023
Equity ratio
95.8%
Financial strength
Net profit 2024
DKK -24,3M
-42% vs 2023
| Revenue | DKK -17,2M | +74% |
| EBITDA | DKK -29,4M | -40% |
| Net profit | DKK -24,3M | -42% |
| Total assets | DKK 28M | -48% |
| Equity | DKK 26,8M | -48% |
| Employees | 18 | — |
Legal name
Chromologics ApS
CVR number
38789953
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28. juni 2017
Share capital
DKK 1.260.786
Employees
18 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i
forening med et bestyrelsesmedlem, bestyrelsesformanden i
forening med en direktør eller af den samlede bestyrelse
Company purpose
Virksomhedens formål er at udvikle nye pigmenter til forskellige formål som inkluderer fødevare, foder, drikkevarer, tekstiler, polymere og andre tekniske anvendelser.
Address
Maskinvej 5
Phone
+4551883057
Email
aodum@chromologics.com
Website
www.chromologics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -0 | 0 | -47 | -729 | -3.414 | -8.170 | -9.884 | -17.218 |
| Staff expenses | -0 | -0 | -0 | -1.307 | -4.215 | -8.006 | -11.070 | -12.215 |
| EBITDA | -0 | -1 | -47 | -2.037 | -7.629 | -16.176 | -20.954 | -29.433 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -221 | -417 | -688 | -881 |
| EBIT | -0 | -1 | -47 | -2.037 | -7.850 | -16.593 | -21.642 | -30.314 |
| Net financials | 0 | 0 | 0 | -136 | -349 | -358 | 899 | 632 |
| Profit before tax | -0 | -1 | -47 | -2.173 | -8.199 | -16.951 | -20.744 | -29.682 |
| Tax | -0 | -0 | -0 | -539 | -1.293 | -3.138 | -3.597 | -5.390 |
| Net profit | -0 | -1 | -47 | -1.634 | -6.907 | -13.813 | -17.147 | -24.293 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 160 | 159 | 399 | 12.973 | 36.482 | 25.143 | 53.594 | 27.981 |
| Equity | 160 | 159 | 111 | 9.377 | 32.078 | 18.265 | 51.112 | 26.819 |
| Long-term debt | 0 | 0 | 0 | 3.163 | 3.363 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 288 | 433 | 1.041 | 6.878 | 2.482 | 1.162 |
| Total debt | 0 | 0 | 288 | 3.596 | 4.404 | 6.878 | 2.482 | 1.162 |
EBITDA margin
-2943294000.0%
This company
15.8%
Market median
-18628443138% vs market
20172024
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20172024
Return on equity
-90.6%
This company
18.4%
Market median
-592% vs market
20172024
Net profit margin
-2429284700.0%
This company
8.1%
Market median
-29991169236% vs market
20172024
Asset turnover
-0.62×
This company
1.12×
Market median
-155% vs market
20172024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-06-28 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GT Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
AS Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
LB | Board of Directors | 2021 | — | — |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novo Holdings A/S | Company | 33.3% | 33.3% | 2025 |
Danmarks Eksport- og Investeringsfond | Company | 15.0% | 15.0% | 2025 |
| Individual | 5.0% | 5.0% | 2025 | |
| Individual | 5.0% | 5.0% | 2025 | |
| Individual | 5.0% | 5.0% | 2023 | |
VÆKSTFONDEN | Company | 5.0% | 5.0% | 2023 |
| Individual | 15.0% | 15.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
Chromologics ApS Board members of Chromologics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerit Tolborg | Chief Executive Officer | 0 companies |
| Anders Sebastian Rosenkrans Ødum | Management | 0 companies |
| Regina Maria Hecker | Board of Directors | 0 companies |
| Thomas Grotkjær | Board of Directors | 0 companies |
| Lauri Johannes Reuter | Board of Directors | 0 companies |
| Sara Sande | Board of Directors | 0 companies |
| Jarne Elleholm | Chairman | 0 companies |
| Henrik Dalbøge | Board of Directors | 0 companies |
| Lea Bajc | Board of Directors | 0 companies |
| Klaus Stegler Bjerrum | Board of Directors | 0 companies |